ATE196165T1 - Methoden zur herstellung von protein c - Google Patents

Methoden zur herstellung von protein c

Info

Publication number
ATE196165T1
ATE196165T1 AT94309314T AT94309314T ATE196165T1 AT E196165 T1 ATE196165 T1 AT E196165T1 AT 94309314 T AT94309314 T AT 94309314T AT 94309314 T AT94309314 T AT 94309314T AT E196165 T1 ATE196165 T1 AT E196165T1
Authority
AT
Austria
Prior art keywords
methods
cell lines
degrees centigrade
producing protein
recombinant proteins
Prior art date
Application number
AT94309314T
Other languages
English (en)
Inventor
Brian William Grinnell
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE196165T1 publication Critical patent/ATE196165T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT94309314T 1993-12-15 1994-12-14 Methoden zur herstellung von protein c ATE196165T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/168,035 US5618714A (en) 1993-12-15 1993-12-15 Methods for producing protein C

Publications (1)

Publication Number Publication Date
ATE196165T1 true ATE196165T1 (de) 2000-09-15

Family

ID=22609820

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94309314T ATE196165T1 (de) 1993-12-15 1994-12-14 Methoden zur herstellung von protein c

Country Status (28)

Country Link
US (1) US5618714A (de)
EP (1) EP0658626B1 (de)
JP (1) JP3662614B2 (de)
KR (1) KR950018454A (de)
CN (1) CN1107887A (de)
AT (1) ATE196165T1 (de)
AU (1) AU687914B2 (de)
BR (1) BR9404991A (de)
CA (1) CA2138101A1 (de)
CO (1) CO4340654A1 (de)
CZ (2) CZ315794A3 (de)
DE (1) DE69425809T2 (de)
DK (1) DK0658626T3 (de)
ES (1) ES2149244T3 (de)
FI (1) FI106385B (de)
GR (1) GR3034909T3 (de)
HU (1) HU219508B (de)
IL (1) IL111983A0 (de)
NO (1) NO944846L (de)
NZ (1) NZ270140A (de)
PE (1) PE42695A1 (de)
PL (1) PL176381B1 (de)
PT (1) PT658626E (de)
RU (1) RU2110574C1 (de)
SI (1) SI0658626T1 (de)
UA (1) UA26870C2 (de)
YU (1) YU73494A (de)
ZA (1) ZA949981B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19724543A1 (de) * 1997-06-11 1998-12-17 Philips Patentverwaltung Wechsler-Gerät für Informationsplatten
WO2002069232A2 (en) 2001-02-19 2002-09-06 Merck Patent Gmbh Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity
US7344873B2 (en) 2002-03-29 2008-03-18 Merck & Co., Inc. Methods of adenovirus production
US20070142272A1 (en) * 2003-01-24 2007-06-21 Zlokovic Berislav V Neuroprotective activity of activated protein c independent of its anticoagulant activity
US20080305100A1 (en) * 2004-07-23 2008-12-11 Zlokovic Berislav V Activated Protein C Inhibits Undesirable Effects of Plasminogen Activator in the Brain
US20090148458A1 (en) * 2005-06-23 2009-06-11 The University Of British Columbia Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapy
US20100041600A1 (en) * 2006-06-09 2010-02-18 Russel James A Interferon gamma polymorphisms as indicators of subject outcome in critically ill subjects
WO2009089620A1 (en) * 2008-01-15 2009-07-23 The Universityof British Columbia Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compound
WO2012068519A2 (en) 2010-11-19 2012-05-24 Sirius Genomics Inc. Markers associated with response to activated protein c administration, and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
US4959318A (en) * 1985-06-27 1990-09-25 Zymogenetics, Inc. Expression of protein C
US4968626A (en) * 1985-08-15 1990-11-06 Board Of Reagents Of The University Of Washington DNA sequence coding for protein C
EP0245949B1 (de) * 1986-04-09 1997-10-29 Eli Lilly And Company Verfahren zur Anwendung von den BK-Virus-Verstärker enthaltenden eukaryotischen Expressionsvektoren
JPH01502080A (ja) * 1986-11-17 1989-07-27 ニュー・イングランド・メディカル・センター 組み換えビタミンｋ依存性蛋白質のガンマカルボキシル化の増強
US4992373A (en) * 1987-12-04 1991-02-12 Eli Lilly And Company Vectors and compounds for direct expression of activated human protein C
ZA889497B (en) * 1987-12-28 1990-08-29 Lilly Co Eli Vectors and compounds for expression of zymogen forms of human protein c
JPH0246296A (ja) * 1988-08-09 1990-02-15 Hoechst Japan Ltd 雑種プロテインｃ及びその製造方法
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
CA1332049C (en) * 1988-10-07 1994-09-20 Eli Lilly And Company Eukaryotic expression
DK0485504T3 (da) * 1989-08-11 1994-04-18 Zymogenetics Inc Fremgangsmåde til fremstilling af aktiveret protein C ved celledyrkning
IL97312A (en) * 1990-02-23 1999-01-26 Lilly Co Eli A method of generating a polypeptide in an eukaryotic vector AND recombinant surrogate cell containing an enhanced transcriptional control unit based on the primary late adenovirus coefficient
JPH05276952A (ja) * 1991-01-29 1993-10-26 Teijin Ltd ヒトプロテインｃ発現ベクター

Also Published As

Publication number Publication date
NO944846L (no) 1995-06-16
FI106385B (fi) 2001-01-31
US5618714A (en) 1997-04-08
AU8045294A (en) 1995-06-22
PE42695A1 (es) 1995-12-12
KR950018454A (ko) 1995-07-22
UA26870C2 (uk) 1999-12-29
FI945877L (fi) 1995-06-16
JP3662614B2 (ja) 2005-06-22
IL111983A0 (en) 1995-03-15
NO944846D0 (no) 1994-12-14
CO4340654A1 (es) 1996-07-30
CN1107887A (zh) 1995-09-06
AU687914B2 (en) 1998-03-05
PL306291A1 (en) 1995-06-26
CZ290724B6 (cs) 2002-10-16
NZ270140A (en) 1996-05-28
DK0658626T3 (da) 2000-10-16
CZ315794A3 (en) 1995-10-18
PL176381B1 (pl) 1999-05-31
DE69425809D1 (de) 2000-10-12
HUT69979A (en) 1995-09-28
JPH07222589A (ja) 1995-08-22
HU9403600D0 (en) 1995-02-28
DE69425809T2 (de) 2001-02-01
RU2110574C1 (ru) 1998-05-10
GR3034909T3 (en) 2001-02-28
SI0658626T1 (en) 2001-02-28
ZA949981B (en) 1996-06-14
EP0658626A1 (de) 1995-06-21
YU73494A (sh) 1997-03-07
CA2138101A1 (en) 1995-06-16
EP0658626B1 (de) 2000-09-06
HU219508B (hu) 2001-04-28
RU94043769A (ru) 1997-03-27
ES2149244T3 (es) 2000-11-01
BR9404991A (pt) 1995-08-08
PT658626E (pt) 2001-01-31
FI945877A0 (fi) 1994-12-14

Similar Documents

Publication Publication Date Title
NO975674D0 (no) Fremgangsmåte for å regulere sialyleringen av proteiner fremstilt av pattedyrceller i kultur
ATE87663T1 (de) Verfahren zur herstellung von faktor-viii:c-typ- proteinen.
ATE124725T1 (de) Verbessertes verfahren zur herstellung von faktor viii:c-typ-proteinen.
DE69434578D1 (de) Expressionsvektoren die für bispezifische Proteine kodieren, und Verfahren zur Herstellung von biologisch-aktiven bispezifischen Fusionsproteine in Zellen von Säugertieren
FI871908A0 (fi) Transformering av trichoderma-moegel.
BR9911549A (pt) Processo de produção de fitase em levedura
FI885679A0 (fi) Samuttryckning i eukariotiska celler.
ATE109829T1 (de) Interleukin-7.
PT1025245E (pt) Criacao rapida de linhas celulares estaveis de mamifero produzindo elevados iiveis de proteinas recombinantes
DE59913565D1 (de) Rekombinanter stabiler zellklon, seine herstellung und verwendung
ATE196165T1 (de) Methoden zur herstellung von protein c
DE69430975D1 (de) Verfahren zur Herstellung von Proteinen
ATE102994T1 (de) Verfahren zur herstellung von proteinen.
ATE109827T1 (de) Verfahren zur herstellung von peptiden, dazu zu verwendendes rekombinantes plasmid und mit diesem plasmid transformierte myelomzellen.
DE3885395D1 (de) Expressionsvektor und Verfahren zur Expression von heterologen Proteinen in Säugerzellen.
ATE97958T1 (de) Zellenzuchtverfahren fuer die produktion von aktiviertem protein-c.
ATE288476T1 (de) Herstellung von proteinen
ATE91303T1 (de) Verfahren zur herstellung von peptiden durch spezifische spaltung von gentechnisch gewonnenen fusionsproteinen mit collagenasen.
KR960017848A (ko) 인간 적혈구 형성 자극 인자의 신규 제조 방법
TH18770A (de)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee